EP3089729A4 - Allantoin compositions for treating inflammatory skin conditions - Google Patents

Allantoin compositions for treating inflammatory skin conditions Download PDF

Info

Publication number
EP3089729A4
EP3089729A4 EP14876324.6A EP14876324A EP3089729A4 EP 3089729 A4 EP3089729 A4 EP 3089729A4 EP 14876324 A EP14876324 A EP 14876324A EP 3089729 A4 EP3089729 A4 EP 3089729A4
Authority
EP
European Patent Office
Prior art keywords
skin conditions
inflammatory skin
treating inflammatory
allantoin
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14876324.6A
Other languages
German (de)
French (fr)
Other versions
EP3089729A1 (en
Inventor
Elliott Farber
Robert Ryan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scioderm Inc
Original Assignee
Scioderm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scioderm Inc filed Critical Scioderm Inc
Publication of EP3089729A1 publication Critical patent/EP3089729A1/en
Publication of EP3089729A4 publication Critical patent/EP3089729A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP14876324.6A 2014-01-03 2014-01-03 Allantoin compositions for treating inflammatory skin conditions Withdrawn EP3089729A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/010248 WO2015102642A1 (en) 2014-01-03 2014-01-03 Allantoin compositions for treating inflammatory skin conditions

Publications (2)

Publication Number Publication Date
EP3089729A1 EP3089729A1 (en) 2016-11-09
EP3089729A4 true EP3089729A4 (en) 2017-06-14

Family

ID=53493841

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14876324.6A Withdrawn EP3089729A4 (en) 2014-01-03 2014-01-03 Allantoin compositions for treating inflammatory skin conditions

Country Status (7)

Country Link
EP (1) EP3089729A4 (en)
JP (1) JP2017502053A (en)
AU (1) AU2014374416A1 (en)
BR (1) BR112016015641A8 (en)
CA (1) CA2935836A1 (en)
MX (1) MX2016008795A (en)
WO (1) WO2015102642A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017501232A (en) * 2013-12-27 2017-01-12 シオデルム， インコーポレイテッド Keloid reduction using local allantoin
GB201607814D0 (en) 2016-05-04 2016-06-15 5D Health Prot Group Ltd Anti-microbial compositions
CN109091478A (en) * 2017-06-20 2018-12-28 中国医学科学院药物研究所 Application of the allantoin in preparation inhibiting hyperuricemia and anti-gout drugs
CN116870157A (en) * 2017-10-20 2023-10-13 日本乐敦制药株式会社 Composition for improving skin disorders
CN111773212A (en) * 2020-08-14 2020-10-16 云南中医药大学 Application of daphnetin

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1579861A2 (en) * 2004-03-26 2005-09-28 Wilhelm R. Wolf Ointment for nail bed care and for the treatment or prophylaxis of nail bed inflammation and/or inflammation of the nasal mucosa
US20060134149A1 (en) * 1999-07-23 2006-06-22 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
WO2015100348A1 (en) * 2013-12-27 2015-07-02 Scioderm, Inc. Keloid reduction using topical allantoin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94806A0 (en) * 1990-06-20 1991-04-15 Ernest Bar On Pharmaceutical preparation containing thiol derivatives together with other active compounds
US6281236B1 (en) * 1999-07-23 2001-08-28 Alwyn Company, Inc. Oil-in-water emulsion with improved stability
US20020054895A1 (en) * 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
WO2009007785A2 (en) * 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US9629785B2 (en) * 2010-10-21 2017-04-25 Cadila Healthcare Limited Pharmaceutical compositions comprising nano size droplets of skin whitening agents
JP5769481B2 (en) * 2011-04-15 2015-08-26 株式会社 資生堂 Topical skin preparation containing ufenamate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134149A1 (en) * 1999-07-23 2006-06-22 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
EP1579861A2 (en) * 2004-03-26 2005-09-28 Wilhelm R. Wolf Ointment for nail bed care and for the treatment or prophylaxis of nail bed inflammation and/or inflammation of the nasal mucosa
WO2015100348A1 (en) * 2013-12-27 2015-07-02 Scioderm, Inc. Keloid reduction using topical allantoin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2015102642A1 *

Also Published As

Publication number Publication date
BR112016015641A8 (en) 2017-10-10
BR112016015641A2 (en) 2017-10-03
EP3089729A1 (en) 2016-11-09
JP2017502053A (en) 2017-01-19
CA2935836A1 (en) 2015-07-09
AU2014374416A1 (en) 2016-07-21
WO2015102642A1 (en) 2015-07-09
MX2016008795A (en) 2017-03-23

Similar Documents

Publication Publication Date Title
HK1243640A1 (en) Methods and compositions for treating ulcers
EP3263132A4 (en) Composition for treating il-6-related diseases
EP3265053A4 (en) Methods for treating skin
EP3115390A4 (en) Isocyanurate composition
EP3154595A4 (en) Treating myelomas
EP3142691A4 (en) Methods and compositions for treating autoimmune and inflammatory conditions
EP3135650A4 (en) Admixture for hydraulic composition
EP3139928A4 (en) Anordrin compositions and methods for treating diseases
PL3261726T3 (en) Composition for the treatment of acne
EP3189074A4 (en) Compositions and methods for treating and preventing inflammation
EP3126004A4 (en) Methods and compositions for treating inflammatory disorders
EP3110446A4 (en) Methods and compositions for treating siglec-8 associated diseases
EP3227276A4 (en) Combinations for the treatment of neuroblastoma
EP3334432A4 (en) Cerdulatinib for treating myeloma
EP3287010A4 (en) Composition for improving food-texture
EP3122349A4 (en) Compositions for the treatment of autodigestion
EP3164139A4 (en) Topical compositions and methods for treating wounds
EP3229813A4 (en) Treatment of hmgb1-mediated inflammation
EP3164132A4 (en) Methods and compositions for treating diseases and conditions
EP3122743A4 (en) Compositions and methods for treating neurodegenerative diseases
EP3206670A4 (en) Compositions for treating wounds
EP3089729A4 (en) Allantoin compositions for treating inflammatory skin conditions
EP3240533A4 (en) Compositions and methods for treating glaucoma
EP3354284A4 (en) Composition for treating pain
EP3200598A4 (en) Compositions for reducing acidity

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160803

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: FARBER, ELLIOTT

Inventor name: RYAN, ROBERT

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170517

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20170511BHEP

Ipc: A61K 8/06 20060101AFI20170511BHEP

Ipc: A61Q 19/00 20060101ALI20170511BHEP

Ipc: A61K 47/06 20060101ALI20170511BHEP

Ipc: A61K 8/49 20060101ALI20170511BHEP

Ipc: A61Q 19/08 20060101ALI20170511BHEP

Ipc: A61K 9/107 20060101ALI20170511BHEP

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SCIODERM, INC.

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1240073

Country of ref document: HK

17Q First examination report despatched

Effective date: 20181107

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190518